Five-Year Allograft Survival for Recipients of Kidney Transplants From Hepatitis C Virus Infected vs Uninfected Deceased Donors in the Direct-Acting Antiviral Therapy Era-Reference-Cited by-同舟云学术

Five-Year Allograft Survival for Recipients of Kidney Transplants From Hepatitis C Virus Infected vs Uninfected Deceased Donors in the Direct-Acting Antiviral Therapy Era

Published:2022-09-20 Issue:11 Volume:328 Page:1102
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Schaubel Douglas E.¹,Tran Amelia H.¹,Abt Peter L.²,Potluri Vishnu S.³,Goldberg David S.⁴,Reese Peter P.³

Affiliation:

1. Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia

2. Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia

3. Renal-Electrolyte and Hypertension Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia

4. Division of Digestive Health and Liver Diseases, Miller School of Medicine at the University of Miami, Miami, Florida

Abstract

This cohort study examines the validity of the Kidney Donor Profile Index’s hepatitis C virus (HCV) penalty during the direct-acting antiviral era by comparing 5-year allograft survival between recipients of kidneys from HCV-RNA–positive donors vs HCV-RNA–negative donors.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2795744/jama_schaubel_2022_ld_220050_1663338167.37987.pdf

Reference6 articles.

1. A comprehensive risk quantification score for deceased donor kidneys.;Rao;Transplantation,2009

2. A review of kidney transplantation from HCV-viremic donors into HCV-negative recipients.;Daloul;Kidney Int,2021

3. Twelve-month outcomes after transplant of hepatitis C–infected kidneys into uninfected recipients.;Reese;Ann Intern Med,2018

4. Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus–infected donors to noninfected recipients.;Durand;Ann Intern Med,2018

5. Trends in discard of kidneys from hepatitis C viremic donors in the United States.;Chang;Clin J Am Soc Nephrol,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age-modified risk factors for mortality of non-elderly adult kidney transplant recipients: a retrospective database analysis;International Urology and Nephrology;2024-06-26

2. Surveillance for donor‐derived infections in Australia;Transplant Infectious Disease;2024-06-10

3. Utilising organs from hepatitis C virus PCR‐positive donors in Western Australia;Internal Medicine Journal;2024-03-07

4. Twelve‐month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients;Transplant Infectious Disease;2023-12-19

5. Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline;Annals of Internal Medicine;2023-12